130 related articles for article (PubMed ID: 38482961)
21. Cochlear implantation in neurofibromatosis type 2 after radiation therapy.
Trotter MI; Briggs RJ
Otol Neurotol; 2010 Feb; 31(2):216-9. PubMed ID: 19887974
[TBL] [Abstract][Full Text] [Related]
22. Intraoperative Cochlear Nerve Monitoring for Vestibular Schwannoma Resection and Simultaneous Cochlear Implantation in Neurofibromatosis Type 2: A Case Series.
Butler MJ; Wick CC; Shew MA; Chicoine MR; Ortmann AJ; Vance J; Buchman CA
Oper Neurosurg (Hagerstown); 2021 Oct; 21(5):324-331. PubMed ID: 34332508
[TBL] [Abstract][Full Text] [Related]
23. Cochlear implantation in the neurofibromatosis type 2 patient: long-term follow-up.
Neff BA; Wiet RM; Lasak JM; Cohen NL; Pillsbury HC; Ramsden RT; Welling DB
Laryngoscope; 2007 Jun; 117(6):1069-72. PubMed ID: 17545869
[TBL] [Abstract][Full Text] [Related]
24. Cochlear Implantation in a Patient with Neurofibromatosis Type 2 and an Intracochlear Schwannoma: A Case Report and Literature Review.
Zhang D; Fu Z; Han S; Guo F; Tang N; Zhao Y; Guan G
ORL J Otorhinolaryngol Relat Spec; 2022; 84(5):425-428. PubMed ID: 35537404
[TBL] [Abstract][Full Text] [Related]
25. Ipsilateral cochlear implantation in patients with sporadic vestibular schwannoma in the only or best hearing ear and in patients with NF2.
Lassaletta L; Aristegui M; Medina M; Aranguez G; Pérez-Mora RM; Falcioni M; Gavilán J; Piazza P; Sanna M
Eur Arch Otorhinolaryngol; 2016 Jan; 273(1):27-35. PubMed ID: 25537817
[TBL] [Abstract][Full Text] [Related]
26. Cochlear Implantation in Neurofibromatosis Type 2: Experience From the UK Neurofibromatosis Type 2 Service.
Smith ME; Edmiston R; Trudel M; Freeman S; Stapleton E; Axon P; Donnelly N; Tysome JR; Bance M; Obholzer R; Jiang D; Mackeith S; Ramsden J; O'Driscoll M; Mawman D; Buttimore J; Nunn T; Humphries J; Evans DG; Lloyd SKW;
Otol Neurotol; 2022 Jun; 43(5):538-546. PubMed ID: 35213477
[TBL] [Abstract][Full Text] [Related]
27. Surgical management of vestibular schwannomas and hearing rehabilitation in neurofibromatosis type 2.
Tysome JR; Macfarlane R; Durie-Gair J; Donnelly N; Mannion R; Knight R; Harris F; Vanat ZH; Tam YC; Burton K; Hensiek A; Raymond FL; Moffat DA; Axon PR
Otol Neurotol; 2012 Apr; 33(3):466-72. PubMed ID: 22334163
[TBL] [Abstract][Full Text] [Related]
28. Hearing restoration in NF2 patients and patients with vestibular schwannoma in the only hearing ear: report of two cases.
Ozdek A; Bayır O; Dönmez T; Ozışık P; Sahin M; Tulgar M; Tatar EÇ; Korkmaz MH
Am J Otolaryngol; 2014; 35(4):538-41. PubMed ID: 24746329
[TBL] [Abstract][Full Text] [Related]
29. Simultaneous Translabyrinthine Tumor Removal and Cochlear Implantation in Vestibular Schwannoma Patients.
Kim JW; Han JH; Kim JW; Moon IS
Yonsei Med J; 2016 Nov; 57(6):1535-9. PubMed ID: 27593888
[TBL] [Abstract][Full Text] [Related]
30. Vestibular schwannoma in the only hearing ear: cochlear implant or auditory brainstem implant?
Ramsden R; Khwaja S; Green K; O'Driscoll M; Mawman D
Otol Neurotol; 2005 Mar; 26(2):261-4. PubMed ID: 15793416
[TBL] [Abstract][Full Text] [Related]
31. Hearing rehabilitation in neurofibromatosis type 2 patients: cochlear versus auditory brainstem implantation.
Vincenti V; Pasanisi E; Guida M; Di Trapani G; Sanna M
Audiol Neurootol; 2008; 13(4):273-80. PubMed ID: 18259080
[TBL] [Abstract][Full Text] [Related]
32. Hearing rehabilitation outcomes in cochlear implant recipients with vestibular schwannoma in observation or radiotherapy groups: A systematic review.
Borsetto D; Hammond-Kenny A; Tysome JR; Axon PR; Donnelly NP; Vijendren A; Phillips V; Bance ML
Cochlear Implants Int; 2020 Jan; 21(1):9-17. PubMed ID: 31496442
[No Abstract] [Full Text] [Related]
33. Management strategy of vestibular schwannoma in neurofibromatosis type 2.
Odat HA; Piccirillo E; Sequino G; Taibah A; Sanna M
Otol Neurotol; 2011 Sep; 32(7):1163-70. PubMed ID: 21817944
[TBL] [Abstract][Full Text] [Related]
34. Speech intelligibility as a predictor of cochlear implant outcome in prelingually deafened adults.
van Dijkhuizen JN; Beers M; Boermans PP; Briaire JJ; Frijns JH
Ear Hear; 2011; 32(4):445-58. PubMed ID: 21258238
[TBL] [Abstract][Full Text] [Related]
35. Long-term functional outcomes and academic-occupational status in implanted children after 10 to 14 years of cochlear implant use.
Beadle EA; McKinley DJ; Nikolopoulos TP; Brough J; O'Donoghue GM; Archbold SM
Otol Neurotol; 2005 Nov; 26(6):1152-60. PubMed ID: 16272934
[TBL] [Abstract][Full Text] [Related]
36. Clinical features of spinal schwannomas in 65 patients with schwannomatosis compared with 831 with solitary schwannomas and 102 with neurofibromatosis Type 2: a retrospective study at a single institution.
Li P; Zhao F; Zhang J; Wang Z; Wang X; Wang B; Yang Z; Yang J; Gao Z; Liu P
J Neurosurg Spine; 2016 Jan; 24(1):145-54. PubMed ID: 26407091
[TBL] [Abstract][Full Text] [Related]
37. Auditory brainstem implants in NF2 patients: results and review of the literature.
Sanna M; Di Lella F; Guida M; Merkus P
Otol Neurotol; 2012 Feb; 33(2):154-64. PubMed ID: 22246383
[TBL] [Abstract][Full Text] [Related]
38. Cochlear Implantation Outcomes in Observed Vestibular Schwannoma: A Preliminary Report.
Longino ES; Manzoor NF; Cass ND; Tawfik KO; Bennett ML; O'Malley MR; Haynes DS; Perkins EL
Otolaryngol Head Neck Surg; 2022 Jul; 167(1):149-154. PubMed ID: 34546801
[TBL] [Abstract][Full Text] [Related]
39. Bilateral intracochlear schwannomas: histopathological confirmation and outcomes following tumour removal and cochlear implantation with lateral wall electrodes.
Quick ME; Withers S; Plontke SK; Chester-Browne R; Kuthubutheen J
HNO; 2023 Dec; 71(12):802-808. PubMed ID: 37904024
[TBL] [Abstract][Full Text] [Related]
40. Long-term functional outcomes of hearing and speech rehabilitation efficacy among paediatric cochlear implant recipients in Shandong, China.
Jiang F; Alimu D; Qin WZ; Kupper H
Disabil Rehabil; 2021 Oct; 43(20):2860-2865. PubMed ID: 32024407
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
